NCT05387889

Brief Summary

The MMPH program will include two Zoom-delivered sessions (Weeks #1 \& #4), six video-recorded sessions (Weeks #2, #3, #5, #6, #7, #8), and daily mindfulness meditation practice using a mobile APP during an eight-week study period. Similar to the Urban Zen Integrative Therapy intervention, each MMPH session will include Gentle Body Movement (GBM,10-min), Restorative Pose (Pose,10-min), and Body Awareness Meditation (BAM, 20-min). Self-guided audio-video modules of various durations will be available according to participants' preference and level of comfort (5, 10, 20 minutes). The mobile-APP content will reinforce Zoom content such as mindful breathing, GBM of upper extremities, GBM of lower extremities, Pose sitting, Pose lying, and BAM practices. The MMPH content will be tailored to health management needs specific to PH with cultural consideration of mindfulness-related concepts (stress, responding to stress, resiliency).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 24, 2022

Completed
24 days until next milestone

Study Start

First participant enrolled

June 17, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2023

Completed
8 months until next milestone

Results Posted

Study results publicly available

November 8, 2023

Completed
Last Updated

November 8, 2023

Status Verified

November 1, 2023

Enrollment Period

6 months

First QC Date

March 25, 2022

Results QC Date

July 12, 2023

Last Update Submit

November 6, 2023

Conditions

Keywords

pulmonary hypertensionracial minoritycomplementary health approachintegrative therapymindfulness-based interventionsymptom managementhealth-related quality of life

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in Depressive Symptoms on the 27-point Patient Health Questionnaire-9 Scales (PHQ-9) to Week #8.

    Patient Health Questionnaire-9 is a validated, self-reported questionnaire assessing depressive symptoms over the past few weeks. Possible scores range from 0 to 27, indicating the levels of depression (0-4 = None or Minimal; 5-9 = Mild; 10-14 = Moderate; 15-19 = Moderately Severe; 20- 27 = Severe). Depressive symptoms comparison between Group 1 and Group 2 at the end of the intervention (Week #8). Depressive symptoms comparison at Baseline vs. Week #8 within Group 1 participants who received the intervention. Depressive symptoms comparison at Baseline vs. Week #8 within Group 2 participants who received the intervention.

    Baseline and at the end of the study intervention (Week #8)

Secondary Outcomes (2)

  • Change From Baseline in PH-related Quality of Life on the 50-point EmPHasis-10 Scales to Week #8.

    Baseline and at the end of the study intervention (Week #8)

  • Change From Baseline in Mindfulness Level on the 40-point Cognitive and Affective Mindfulness Scale-Revised (CAMS-R) to Week #8.

    Baseline and at the end of the study intervention (Week #8)

Study Arms (2)

Treatment Arm

EXPERIMENTAL

This treatment Arm will receive MMPH intervention first, while the wait-listed group waits until this group is complete. Then the wait-listed group will receive the same intervention after the first group completes it.

Behavioral: Mindfulness Meditation for Pulmonary Hypertension (MMPH)

Comparison Arm or Waited List Arm

ACTIVE COMPARATOR

This active comparator Arm will not receive MMPH intervention at the beginning. They will receive the intervention once the Treatment Group completed the intervention.

Behavioral: Mindfulness Meditation for Pulmonary Hypertension (MMPH)

Interventions

Eight weeks of Mindfulness Meditation practice for patients with Pulmonary Hypertension condition. The content will focus on how to apply Mindfulness concepts to the everyday management of symptoms and stress.

Also known as: MMPH intervention
Comparison Arm or Waited List ArmTreatment Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (\>18 years)
  • PH confirmed by standard guidelines
  • Self-identified as URM person
  • Willingness to participate in the mindfulness practice program for the duration of the study period
  • Able to ambulate independently
  • English-speaking
  • Have access to a mobile phone

You may not qualify if:

  • Known pregnancy
  • Have psychiatric conditions requiring hospitalization within the last year
  • Current practitioner of mind-body practices
  • Current user of Mindfulness APP
  • Deaf or hard of hearing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SUNY at Buffalo School of Nursing

Buffalo, New York, 14214, United States

Location

MeSH Terms

Conditions

Hypertension, Pulmonary

Interventions

Mindfulness

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Dr. Tania Von Visger
Organization
State University of New York at Buffalo School of Nursing

Study Officials

  • Tania Von Visger

    State University of New York at Buffalo School of Nursing

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
All participants will receive intervention according to the wait-listed control comparative groups. Therefore, masking is not applicable in this study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: wait-listed control comparative groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 25, 2022

First Posted

May 24, 2022

Study Start

June 17, 2022

Primary Completion

November 30, 2022

Study Completion

February 28, 2023

Last Updated

November 8, 2023

Results First Posted

November 8, 2023

Record last verified: 2023-11

Locations